Full Text Journal Articles by
Author Ersan Bulut


Find full text journal articles

Comparison of Two Different Anesthesia Methods in Patients Undergoing Percutaneous Nephrolithotomy.

Mehmet Solakhan, Ersan Bulut, Mehmet Sakip Erturhan,

<h4>Purpose</h4>The study aims to compare the effectiveness, safety and costs of two different anesthesia methods in percutaneous nephrolithotomy (PCNL) operations.<h4>Material and method</h4>In our study, data was retrospectively examined of 1657 patients who underwent PCNL due to renal calculi between 2009 and 2017. Patients were separated into two groups according to ... Read more >>

Urol J (Urology journal)
[2019, 16(3):246-250]

Cited: 0 times

View full text PDF listing >>

The effect of an antifibrotic agent, pirfenidone, on penile erectile function in an experimental rat model of ischemic priapism.

Onder Cinar, Mustafa S Bolat, Salih Erdem, Esin Kaymaz, Engin D Demirkiran, Reha Girgin, Ersan Bulut, Bulent Akduman, Necmettin A Mungan,

To date, no effective medical approach for the treatment of erectile dysfunction (ED) secondary to ischemic priapism (IP) has been described. The aim of this study was to evaluate the anti-inflammatory, antifibrotic, and antioxidant effects of pirfenidone (PFD) on cavernosal tissue in a rat model of IP. Forty-eight male albino ... Read more >>

Int J Impot Res (International journal of impotence research)
[2020, 32(2):232-238]

Cited: 0 times

View full text PDF listing >>


Efficacy of mirabegron in medical expulsive therapy.

Mehmet Solakhan, Omer Bayrak, Ersan Bulut,

To show the efficacy of mirabegron for medical expulsive treatment, in patients had intramural located distal ureteral stone. A 80 patients had intramural ureteral stone were assessed retrospectively between April 2017 and January 2018. Mirabegron 50 mg/day + diclofenac 100 mg/day (group 1, n = 40), and only diclofenac 100 mg/day (group 2, n = 40) were administered to ... Read more >>

Urolithiasis (Urolithiasis)
[2019, 47(3):303-307]

Cited: 1 time

View full text PDF listing >>

Quadratus Lumborum Block III for Postoperative Pain After Percutaneous Nephrolithotomy.

Ertuğrul Kılıç, Ersan Bulut,

Objective:An effective pain control is important in early mobilization and returning to normal daily life following percutaneous nephrolithotomy (PCNL) operations. The use of an intraoperative local anaesthetic or postoperative analgesic has been reported for pain control in PCNL. Transmuscular quadratus block (QLB III) is a regional anaesthetic technique applied under ... Read more >>

Turk J Anaesthesiol Reanim (Turkish journal of anaesthesiology and reanimation)
[2018, 46(4):272-275]

Cited: 3 times

View full text PDF listing >>

Preliminary feasibility study of a new method of hypothermia in an experimental canine model.

İbrahim Ünal Sert, Murat Akand, Özcan Kılıç, Nuri Yavru, Ersan Bulut,

<h4>Objective</h4>To build up a new microcontroller thermoelectric system to achieve renal hypothermia.<h4>Material and methods</h4>Renal hypothermia system was tested under in vivo conditions in the kidneys of ten Mongrel dogs. Ambient temperature was evaluated using two different microcontrollers. In order to ensure hypothermia in the renal parenchyma, selection can be made ... Read more >>

Turk J Urol (Turkish journal of urology)
[2017, 43(3):330-336]

Cited: 0 times

View full text PDF listing >>

When routine D-J implantation necessary during PNL?

Omer Bayrak, Ilker Seckiner, Sakip M Erturhan, Ersan Bulut, Asaf Demirbag, Asaf Erbagci,

<h4>Objective</h4>We investigated the characteristics of patients who underwent Double-J catheter (D-J) implantation, the risk factors for prolonged urine leakage (PUL), and prediction of patients who require medical treatment.<h4>Methods</h4>The data of 535 adult patients who underwent PNL due to kidney stone disease between January 2005 and December 2011 in our clinic ... Read more >>

Arch Esp Urol (Archivos espanoles de urologia)
[2015, 68(2):172-177]

Cited: 0 times

View full text PDF listing >>

Evaluation of EGFR, KRAS and BRAF gene mutations in renal cell carcinoma.

Omer Bayrak, Haluk Sen, Ersan Bulut, Beyhan Cengiz, Metin Karakok, Sakip Erturhan, Ilker Seckiner,

A subset of renal cell carcinoma (RCC) patients has been shown to respond to anti-EGFR therapy. As KRAS and BRAF mutations are associated with poor response to anti-EGFR therapy in some cancers, it has been suggested that screening for KRAS and BRAF mutations in RCC may be a promising strategy ... Read more >>

J Kidney Cancer VHL (Journal of kidney cancer and VHL)
[2014, 1(4):40-45]

Cited: 5 times

View full text PDF listing >>



0.7272 s